Abstract 73: Results of DEFUSE 2: Clinical Endpoints
Maarten G. Lansberg(Stanford University), Tudor G. Jovin(Cooper University Hospital), Michael Mlynash(Stanford University), Michael J Wilder(University of Utah), Aaryani Tipirneni‐Sajja(Stanford Medicine), Lawrence R. Wechsler(Hospital of the University of Pennsylvania), Gregory W. Albers(Stanford University), Manabu Inoue(National Cerebral and Cardiovascular Center), Scott Hamilton(Palo Alto University), Stephanie Kemp(Stanford Medicine), Cherylee W. J. Chang, Michael P. Marks(Stanford Medicine), Helmi L. Lutsep(Oregon Health & Science University), Franz Fazekas(Medical University of Graz), Greg Zaharchuk(Stanford University), Todd Czartoski(Swedish Medical Center), Steven Warach(The University of Texas at Austin), Matús Straka(Stanford Medicine), Richard A. Bernstein(Northwestern University), Roland Bammer(Vita-Salute San Raffaele University), Demi Thai(Stanford Medicine)
Cited by 4
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials
|The Lancet|2016|7.6k
Randomized Assessment of Rapid Endovascular Treatment of Ischemic Stroke
|New England Journal of Medicine|2015|6k
Thrombectomy 6 to 24 Hours after Stroke with a Mismatch between Deficit and Infarct
|New England Journal of Medicine|2017|5.5k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k